Testosterone is the primary male hormone, and it contributes to a host of normal physiological processes in the body, including hair growth, muscle mass, sexual desire, and erectile function. It is also essential for maintaining typical male characteristics.

In general, hormone replacement therapy produces gradual results. Treatments build on each other until you achieve a hormone level that is appropriate for your body chemistry. After the first treatment, patients can expect to see results in about two to four weeks, regardless of which treatment method is used.

The influx of testosterone will help promote the release of serotonin in men and can result in an increase in sex drive, energy, and strength. Other benefits, such as reduced depression or anxiety, improved memory, or reduced risk of diabetes and heart attack may accompany this.

The U.S. Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), for use in addition to a reduced calorie diet and increased physical activity. This under-the-skin injection is the first approved drug for chronic weight management in adults with general obesity or overweight since 2014. The drug is indicated for chronic weight management in patients with a body mass index (BMI) of 27 kg/m2 or greater who have at least one weight-related ailment or in patients with a BMI of 30 kg/m2 or greater.

Read more at: https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014